Pharmocann Global Salute del bilancio
Salute finanziaria criteri di controllo 3/6
Pharmocann Global has a total shareholder equity of ₪223.0K and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪2.2M and ₪2.0M respectively.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
₪0
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | ₪612.00k |
| Patrimonio netto | ₪223.00k |
| Totale passività | ₪1.95m |
| Totale attività | ₪2.18m |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Analisi della posizione finanziaria
Passività a breve termine: PMCN-M's short term assets (₪1.1M) do not cover its short term liabilities (₪1.8M).
Passività a lungo termine: PMCN-M's short term assets (₪1.1M) exceed its long term liabilities (₪151.0K).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: PMCN-M is debt free.
Riduzione del debito: PMCN-M has no debt compared to 5 years ago when its debt to equity ratio was 0.7%.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: PMCN-M has less than a year of cash runway based on its current free cash flow.
Previsione Cash Runway: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.9% each year